Posted 30 July 2021 | By Kari Oakes A small Georgia pharmaceutical company has received a notice of noncompliance from the US Food and Drug Administration (FDA) for not registering clinical trial results in a central government registry, as required by federal law. The 26 July letter is the second issued by the FDA for noncompliance with federal...
